These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 18824414

  • 1. Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients.
    Cai L, Zhang Z, Zhou L, Wang H, Fu J, Zhang S, Shi M, Zhang H, Yang Y, Wu H, Tien P, Wang FS.
    Clin Immunol; 2008 Dec; 129(3):428-37. PubMed ID: 18824414
    [Abstract] [Full Text] [Related]

  • 2. Expression of inhibitory receptors in natural killer (CD3(-)CD56(+)) cells and CD3(+)CD56(+) cells in the peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with primary hepatocellular carcinoma.
    Yuen MF, Norris S.
    Clin Immunol; 2001 Dec; 101(3):264-9. PubMed ID: 11726217
    [Abstract] [Full Text] [Related]

  • 3. [Characteristics of peripheral NK cells in hepatocellular carcinoma patients].
    Zhou L, Cai L, Zhang Z, Yang YP, Wang FS.
    Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):136-9. PubMed ID: 20196954
    [Abstract] [Full Text] [Related]

  • 4. Radiofrequency thermal ablation for hepatocellular carcinoma stimulates autologous NK-cell response.
    Zerbini A, Pilli M, Laccabue D, Pelosi G, Molinari A, Negri E, Cerioni S, Fagnoni F, Soliani P, Ferrari C, Missale G.
    Gastroenterology; 2010 May; 138(5):1931-42. PubMed ID: 20060829
    [Abstract] [Full Text] [Related]

  • 5. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells.
    Unitt E, Rushbrook SM, Marshall A, Davies S, Gibbs P, Morris LS, Coleman N, Alexander GJ.
    Hepatology; 2005 Apr; 41(4):722-30. PubMed ID: 15791620
    [Abstract] [Full Text] [Related]

  • 6. Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells.
    Carrega P, Morandi B, Costa R, Frumento G, Forte G, Altavilla G, Ratto GB, Mingari MC, Moretta L, Ferlazzo G.
    Cancer; 2008 Feb 15; 112(4):863-75. PubMed ID: 18203207
    [Abstract] [Full Text] [Related]

  • 7. Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells.
    Hirofuji H, Kakumu S, Fuji A, Ohtani Y, Murase K, Tahara H.
    Clin Exp Immunol; 1987 May 15; 68(2):348-56. PubMed ID: 2820634
    [Abstract] [Full Text] [Related]

  • 8. [Identification of immunological effector cells after autologous cytokine-induced killer cells treatment and its clinical implication in hepatocellular carcinoma patients].
    Shi M, Zhang B, Tang ZR, Lei ZY, Wang HF, Feng YY, Liu JC, Fan ZP, Li HW, Mu JS, Wang FS.
    Zhonghua Yi Xue Za Zhi; 2003 Dec 10; 83(23):2049-53. PubMed ID: 14703414
    [Abstract] [Full Text] [Related]

  • 9. Decrease in intrahepatic CD56+ lymphocytes in gastric and colorectal cancer patients with liver metastases.
    Gulubova M, Manolova I, Kyurkchiev D, Julianov A, Altunkova I.
    APMIS; 2009 Dec 10; 117(12):870-9. PubMed ID: 20078551
    [Abstract] [Full Text] [Related]

  • 10. The regulatory role of natural killer cells in multiple sclerosis.
    Takahashi K, Aranami T, Endoh M, Miyake S, Yamamura T.
    Brain; 2004 Sep 10; 127(Pt 9):1917-27. PubMed ID: 15229129
    [Abstract] [Full Text] [Related]

  • 11. [Hepatocarcinoma and killer cell activity].
    Lucea D, Vargas V, Español T, Castells L, Sauleda S, Esteban R, Guardia J.
    Med Clin (Barc); 1995 Sep 30; 105(10):370-3. PubMed ID: 7475439
    [Abstract] [Full Text] [Related]

  • 12. Direct and natural killer cell-mediated antitumor effects of low-dose bortezomib in hepatocellular carcinoma.
    Armeanu S, Krusch M, Baltz KM, Weiss TS, Smirnow I, Steinle A, Lauer UM, Bitzer M, Salih HR.
    Clin Cancer Res; 2008 Jun 01; 14(11):3520-8. PubMed ID: 18519785
    [Abstract] [Full Text] [Related]

  • 13. Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans.
    Ishiyama K, Ohdan H, Ohira M, Mitsuta H, Arihiro K, Asahara T.
    Hepatology; 2006 Feb 01; 43(2):362-72. PubMed ID: 16440347
    [Abstract] [Full Text] [Related]

  • 14. Perturbations of natural killer cell regulatory functions in respiratory allergic diseases.
    Scordamaglia F, Balsamo M, Scordamaglia A, Moretta A, Mingari MC, Canonica GW, Moretta L, Vitale M.
    J Allergy Clin Immunol; 2008 Feb 01; 121(2):479-85. PubMed ID: 18061653
    [Abstract] [Full Text] [Related]

  • 15. Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment.
    Gonzalez VD, Falconer K, Björkström NK, Blom KG, Weiland O, Ljunggren HG, Alaeus A, Sandberg JK.
    J Immunol; 2009 Nov 15; 183(10):6612-8. PubMed ID: 19846870
    [Abstract] [Full Text] [Related]

  • 16. Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure.
    Golden-Mason L, Madrigal-Estebas L, McGrath E, Conroy MJ, Ryan EJ, Hegarty JE, O'Farrelly C, Doherty DG.
    Gut; 2008 Aug 15; 57(8):1121-8. PubMed ID: 18372499
    [Abstract] [Full Text] [Related]

  • 17. [The presence and the significance of CD4+CD25+ regulatory T cells in livers of patients with hepatocellular carcinoma].
    Yang XH, Liu BR, Jiang HC.
    Zhonghua Gan Zang Bing Za Zhi; 2007 Apr 15; 15(4):279-82. PubMed ID: 17456316
    [Abstract] [Full Text] [Related]

  • 18. Diminished absolute counts of CD56dim and CD56bright natural killer cells in peripheral blood from Egyptian patients with hepatocellular carcinoma.
    Fathy A, Eldin MM, Metwally L, Eida M, Abdel-Rehim M.
    Egypt J Immunol; 2009 Apr 15; 16(2):17-25. PubMed ID: 22059350
    [Abstract] [Full Text] [Related]

  • 19. Dysregulation of blood lymphocyte subsets and natural killer cells in schistosomal liver cirrhosis and hepatocellular carcinoma.
    Attallah AM, Tabll AA, El-Sadany M, Ibrahim TA, El-Dosoky I.
    Clin Exp Med; 2003 Nov 15; 3(3):181-5. PubMed ID: 14648234
    [Abstract] [Full Text] [Related]

  • 20. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma.
    Ormandy LA, Hillemann T, Wedemeyer H, Manns MP, Greten TF, Korangy F.
    Cancer Res; 2005 Mar 15; 65(6):2457-64. PubMed ID: 15781662
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.